Dr. Agarwal's Health Care Limited has announced that its officials will participate in a series of investor conferences and meetings scheduled from May 28, 2026, to June 16, 2026. The disclosure was made in accordance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The scheduled meetings will cover both group and one-on-one interactions and will be conducted in physical mode across various locations. The events are organized by prominent financial institutions, including 360 ONE Capital, Avendus, and Kotak.

Schedule of Meetings

The following table outlines the specific dates, organizers, and locations for the upcoming investor interactions:

Disclosure Policy

The company stated that these meetings will adhere to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. Consequently, no unpublished price-sensitive information or forward-looking statements will be disclosed or discussed during the analyst and investor meetings. Dr. Agarwal's Health Care Limited also noted that the schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company.

Dr. Agarwal's Health Care Limited has disclosed the receipt of a Show Cause Notice (SCN) from the Office of the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai. The notice, dated May 18, 2026, alleges specific discrepancies regarding the returns and statements filed by the company for the financial year 2023-24.

Details of the Discrepancies

The authorities have cited several issues in the SCN, including a difference in output turnover and short payment of tax under the Reverse Charge Mechanism (RCM). Other allegations involve exempted, nil-rated, or non-GST supplies, an excess claim of Input Tax Credit (ITC), and the claim of ineligible ITC. The notice also points to non-compliance with e-invoicing norms and penalties for late or improper reporting.

Financial Implications

As per the SCN, the company is required to show cause within 30 days of receipt as to why a GST demand of Rs. 20.50 Crores, including interest and penalty, should not be levied. In response to the disclosure, the company management stated that it is currently examining the notice and intends to take appropriate steps, including the submission of a reply within the stipulated time frame.

The company further clarified that it does not envisage any relevant impact on its financials, operations, or other activities as a result of this notice.